drugset / Trial / NCT02281448
Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive.
RandomizedCrossoverOpen-labelTreatment
Summary
Single centre, two-way crossover, randomised, open-label study in 20 healthy female volunteers.The volunteers received an oral single-dose of a combined contraceptive containing with an oral once daily dose of 1200 mg of BIA 2-093
Timeline
- Start
- 2005-03
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 1200 mg | Oral |
| Subject | Levonorgestrel | Small molecule | 150 ug | Oral |
| Subject | ethinyl estradiol | Small molecule | 30 ug | Oral |